Changing the pathophysiology of solid tumours: the potential of TNF and other vasoactive agents.
about
Current status of antivascular therapy and targeted treatment in the clinic.The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma.TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long-term patient outcome.Oncological outcome of primary non-metastatic soft tissue sarcoma treated by neoadjuvant isolated limb perfusion and tumor resection.Regional chemotherapy by isolated limb perfusion prior to surgery compared with surgery and post-operative radiotherapy for primary, locally advanced extremity sarcoma: a comparison of matched cohorts.
P2860
Changing the pathophysiology of solid tumours: the potential of TNF and other vasoactive agents.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Changing the pathophysiology o ...... F and other vasoactive agents.
@ast
Changing the pathophysiology o ...... F and other vasoactive agents.
@en
type
label
Changing the pathophysiology o ...... F and other vasoactive agents.
@ast
Changing the pathophysiology o ...... F and other vasoactive agents.
@en
prefLabel
Changing the pathophysiology o ...... F and other vasoactive agents.
@ast
Changing the pathophysiology o ...... F and other vasoactive agents.
@en
P2860
P1476
Changing the pathophysiology o ...... F and other vasoactive agents.
@en
P2093
Alexander M M Eggermont
Timo L M ten Hagen
P2860
P304
P356
10.1080/02656730600738616
P577
2006-05-01T00:00:00Z